Full-Time

Head of Machine Learning Research

Confirmed live in the last 24 hours

Genesis Therapeutics

Genesis Therapeutics

51-200 employees

AI-driven drug discovery for pharmaceuticals

AI & Machine Learning
Biotechnology

Senior

Burlingame, CA, USA

Hybrid position based in Burlingame, CA.

Category
Applied Machine Learning
Deep Learning
AI & Machine Learning
Required Skills
Tensorflow
Pytorch
Requirements
  • PhD in Computer Science, Machine Learning, Physics, or a related field.
  • 8+ years of professional experience in machine learning research, with at least 3+ years in a leadership role managing research teams.
  • Strong track record of developing and applying ML methods in areas such as deep learning, generative models, graph neural networks, or equivariant neural networks.
  • Proven expertise in leveraging ML techniques for real-world problems.
  • Experience with state-of-the-art ML frameworks (e.g., PyTorch, TensorFlow, JAX) and distributed computing environments.
  • Demonstrated ability to lead, mentor, and inspire a diverse team of researchers and engineers.
  • Exceptional communication and collaboration skills, with experience bridging the gap between research and application.
  • Strategic thinking with a balance of creativity and execution focus.
Responsibilities
  • Develop and implement the strategic vision for the ML Research group, ensuring alignment with company goals.
  • Serve as a thought leader in state-of-the art ML research, using the latest approaches in diffusion models, equivariant neural nets and predictive ML.
  • Represent Genesis Therapeutics at conferences, workshops, and scientific forums.
  • Guide the team in designing, implementing, and validating novel machine learning models tailored to drug discovery challenges, including molecular property prediction, generative modeling, and protein-ligand interactions.
  • Prioritize and balance short-term project deliverables with long-term foundational research initiatives.
  • Ensure high standards of scientific rigor and reproducibility in research outputs.
  • Pioneer cutting edge research and original publications in top industry journals and conferences, including NeurIPS, ICML and more.
  • Partner with cross-disciplinary teams, including computational chemists, software engineers, and drug discovery scientists, to deliver impactful ML-driven solutions.
  • Collaborate with the Engineering team to deploy ML models into scalable production environments.
  • Communicate findings and progress effectively to stakeholders at all levels: from interns to board of directors.
  • Manage budgets, resource allocation, and project timelines for the ML Research group.
  • Identify and establish external collaborations and partnerships to augment in-house capabilities.
  • Lead and mentor a high-performing team of ML Research Scientists and ML Research Engineers.
  • Foster a collaborative, innovative, and growth-oriented team culture.
  • Manage recruitment, performance evaluations, and career development for team members.

Genesis Therapeutics uses artificial intelligence to accelerate the development of new medicines in the pharmaceutical industry. By combining 3D spatial graph modeling and molecular simulation, the company identifies potential drug candidates and explores new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The company's goal is to transform drug discovery and efficiently bring critical new medicines to market.

Company Stage

Series B

Total Funding

$272.5M

Headquarters

Burlingame, California

Founded

2019

Growth & Insights
Headcount

6 month growth

14%

1 year growth

45%

2 year growth

131%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with NVIDIA boosts AI platform GEMS for targeting undruggable diseases.
  • Strategic collaboration with Gilead accelerates development of novel small molecule therapies.
  • Recognition as a 'Fierce 15' company highlights Genesis' innovative AI-driven drug discovery.

What critics are saying

  • Competition from AI-driven drug discovery companies like Insilico Medicine and Exscientia.
  • Potential over-reliance on partnerships with large pharmaceutical companies for financial stability.
  • Rapid AI development may render current platforms obsolete without continuous innovation.

What makes Genesis Therapeutics unique

  • Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.
  • The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.
  • Partnerships with NVIDIA and Gilead enhance Genesis' AI capabilities and drug discovery potential.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program